Single-center, single-arm exploratory trial of Deucravacitinib in the treatment of refractory localized scleroderma (ChiCTR) - Oct 16, 2026 - P=N/A | N=10 | Not yet recruiting | Sponsor: Dematology Hospital of Southern Medical University; Dematology Hospital of Southern Medical University
New trial • Immunology • Scleroderma • Systemic Sclerosis
|